Trending Videos
Shorts

1:12
Belzutifan plus lenvatinib offers a new option after IO in ccRCC
20 hours ago
by
Mina M. Fam, MD

1:01
Decipher score may help guide short-term ADT use
2 days ago
by
Angela Jia, MD, PhD

1:05
Cost-effectiveness model favors beta-3 agonists for OAB
3 days ago
by
Anjali Kapur, MD

1:21
New treatment options complicate BCG-unresponsive NMIBC care
4 days ago
by
Adam B. Weiner, MD(+1 more)

1:29
Why female sexual health is often overlooked in bladder cancer care
5 days ago
by
Armine K. Smith, MD

1:07
How APPs can expand access to clinical trials
9 days ago
by
Mary Dunn, MSN, RN, NP-C, OCN

0:28
What policymakers must do to preserve patient choice
11 days ago
by
Celeste Kirschner, CAE, MHSA

1:14
Why the bladder diary matters in nocturia workup
12 days ago
by
Kari A.O. Tikkinen, MD, PhD

0:50
3 actionable steps to improve PSMA-PET access
15 days ago
by
Juan Gómez Rivas, MD, FEBU, PhD

0:23
Site-neutral payment and the future of community urology
15 days ago
by
Celeste Kirschner, CAE, MHSA
Advertisement
Advertisement






























